Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway
暂无分享,去创建一个
Xuetao Cao | Jianli Wang | Qingqing Wang | Lie Wang | Zhou Yu | Zhijian Cai | Yunshan Yang | Fei Yang | Lingling Jiang | Lei Yu
[1] K. Kwack,et al. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. , 2011, DNA and cell biology.
[2] Clotilde Théry,et al. Exosomes: immune properties and potential clinical implementations , 2011, Seminars in Immunopathology.
[3] D. Kwong,et al. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway , 2011, Gut.
[4] H. Toivonen,et al. Modeling Reveals That Dynamic Regulation of c-FLIP Levels Determines Cell-to-Cell Distribution of CD95-mediated Apoptosis* , 2011, The Journal of Biological Chemistry.
[5] I. B. Borel Rinkes,et al. CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. , 2010, Journal of hepatology.
[6] J. Xiang,et al. Dendritic Cells Recruit T Cell Exosomes via Exosomal LFA-1 Leading to Inhibition of CD8+ CTL Responses through Downregulation of Peptide/MHC Class I and Fas Ligand-Mediated Cytotoxicity , 2010, The Journal of Immunology.
[7] Yoo-Seok Yoon,et al. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis , 2010, Journal of Clinical Pathology.
[8] Li-Ping Liu,et al. The Role of NF-κB in Hepatitis B Virus X Protein-Mediated Upregulation of VEGF and MMPs , 2010, Cancer investigation.
[9] Christine Feig,et al. CD95/Fas promotes tumour growth , 2010, Nature.
[10] L. Mincheva-Nilsson,et al. REVIEW ARTICLE: The Role of Placental Exosomes in Reproduction , 2010, American journal of reproductive immunology.
[11] I. Sancho-Martinez,et al. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. , 2010, Immunity.
[12] T. Wang,et al. Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver. , 2009, Gastroenterology.
[13] J. Eriksson,et al. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability , 2009, Cell Death and Differentiation.
[14] Xuetao Cao,et al. Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE21 , 2009, Journal of Immunology.
[15] S. Hedrick,et al. The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival1 , 2008, The Journal of Immunology.
[16] J. Serody,et al. Tumorigenesis and Neoplastic Progression C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9 , 2010 .
[17] I. Sancho-Martinez,et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma. , 2008, Cancer cell.
[18] C. Shaha,et al. Up-Regulation of Bcl-2 through ERK Phosphorylation Is Associated with Human Macrophage Survival in an Estrogen Microenvironment1 , 2007, The Journal of Immunology.
[19] D. McMillin,et al. Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation , 2006, Clinical Cancer Research.
[20] Xuetao Cao,et al. Efficient induction of antitumor T cell immunity by exosomes derived from heat‐shocked lymphoma cells , 2006, European journal of immunology.
[21] Taoyong Chen,et al. More Efficient Induction of HLA-A*0201-Restricted and Carcinoembryonic Antigen (CEA)–Specific CTL Response by Immunization with Exosomes Prepared from Heat-Stressed CEA-Positive Tumor Cells , 2005, Clinical Cancer Research.
[22] J. Xiang,et al. CD4−8− Dendritic Cells Prime CD4+ T Regulatory 1 Cells to Suppress Antitumor Immunity1 , 2005, The Journal of Immunology.
[23] D. Lawrence,et al. Selective Knockdown of the Long Variant of Cellular FLICE Inhibitory Protein Augments Death Receptor-mediated Caspase-8 Activation and Apoptosis* , 2005, Journal of Biological Chemistry.
[24] A. Viola,et al. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers , 2005, The Journal of experimental medicine.
[25] P. Krammer,et al. c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* , 2005, Journal of Biological Chemistry.
[26] S. Orecchia,et al. FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells , 2004, Oncogene.
[27] M. Peter,et al. CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells , 2004, The EMBO journal.
[28] H. Stein,et al. c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis , 2004, The Journal of experimental medicine.
[29] D. Green,et al. Activation‐induced cell death in T cells , 2003, Immunological reviews.
[30] Robert L Fine,et al. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. , 2003, Cancer research.
[31] M. Heyman,et al. The epithelial cell cytoskeleton and intracellular trafficking. II. Intestinal epithelial cell exosomes: perspectives on their structure and function. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[32] Xiaolu Yang,et al. c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.
[33] M. Sporn,et al. An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis* , 2002, The Journal of Biological Chemistry.
[34] J. Tschopp,et al. NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.
[35] F. Martinon,et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways , 2000, Current Biology.
[36] Y. Ikawa,et al. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation. , 2000, Cancer research.
[37] M. Martínez-Lorenzo,et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. , 1999, Journal of immunology.
[38] M. Cohen,et al. Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7. , 1998, Cancer research.
[39] D. Ferrari,et al. Apoptosis signaling by death receptors. , 1998, European journal of biochemistry.
[40] H. Kalthoff,et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. , 1998, Cancer research.
[41] J. Yanagisawa,et al. The Molecular Interaction of Fas and FAP-1 , 1997, The Journal of Biological Chemistry.
[42] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[43] A. Hayday,et al. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice , 1996, The Journal of experimental medicine.
[44] R. Fridman,et al. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). , 1995, Cancer research.
[45] John Calvin Reed,et al. FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.
[46] R. Johnstone,et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.
[47] Sun-Mi Park,et al. CD95 promotes tumour growth , 2011, Nature.
[48] M. Peter,et al. The CD95(APO-1/Fas) DISC and beyond , 2003, Cell Death and Differentiation.
[49] Germaine Greer,et al. van Deventer H , 1968 .